Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Glutamine preconditioning protects against local and systemic injury induced by orthopaedic surgery
Authors
Colin G. Murphy
R. Stapelton
G. C. Chen
D. C. Winter
D. J. Bouchier-Hayes
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 4/2012
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-011-0084-7

Other articles of this Issue 4/2012

The journal of nutrition, health & aging 4/2012 Go to the issue

JNHA: Nutrition

Screening for frailty in elderly emergency department patients by using the Identification of Seniors At Risk (ISAR)

JNHA: Clinical Trials and Aging

Task force on Alzheimer’s disease trial methodology: Recruitment and retention, data management and analysis. The use of imaging in recruitment: Maintenance and methodological issues in Alzheimer’s trials

Is There a Rationale for Including Only Patients Already Being Treated with Cetylcholinesterase

Is there a rationale for including only patients already being treated with acetylcholinesterase inhibitors in a prodromal AD trial?

JNHA: Clinical Trials and Aging

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

JNHA: Clinical Neurosciences

Hydration and cognitive performance

JNHA: Nutrition

New therapeutic targets in dermatoporosis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits